Cephalotaxine Inhibits Zika Infection by Impeding Viral Replication and Stability

Overview

Journal Biochem Biophys Res Commun

Publisher Elsevier

Specialty Biochemistry

Date 2019 Dec 11

PMID 31818462

Citations 9

Authors

Zheng-Zong Lai

Yi-Jung Ho

Jeng-Wei Lu

Affiliations

Soon will be listed here.

Abstract

The Zika virus (ZIKV) is a mosquito-borne flavivirus that has reemerged as a serious public health problem around the world. Syndromes of infected people range from asymptomatic infections to severe neurological disorders, such as Guillain-Barré syndrome and microcephaly. Screening anti-ZIKV drugs derived from Chinese medicinal herbs is one method of identifying antiviral agents. In this paper, we report that (1) Cephalotaxine (CET), an alkaloid isolated from Cephalotaxus drupacea, was effective in inhibiting ZIKV activity in vitro (i.e., in Vero and A549 cell lines) and (2) the mechanisms which underlie these effects involve virucidal activity and a decrease in viral replication. Specifically, CET was found to decrease ZIKV RNA and viral protein expression, inhibit ZIKV replication, and inhibit ZIKV mRNA/protein production. We also determined that CET is effective in inhibiting dengue virus 1-4 (DENV1-4). Taken together, our findings indicate that CET could be an effective lead compound in the treatment of ZIKV and also suggest that further investigation and development of CET-derived drugs may lead to a new class of anti-Flavivirus medications.

Citing Articles

An Overview of Zika Virus and Zika Virus Induced Neuropathies.

Wahaab A, Mustafa B, Hameed M, Batool H, Tran Nguyen Minh H, Tawaab A Int J Mol Sci. 2025; 26(1.

PMID: 39795906 PMC: 11719530. DOI: 10.3390/ijms26010047.

Natural Products and Derivatives as Potential Inhibitors: A Comprehensive Review.

Pereira R, Santos F, Campana P, Costa V, Padua R, Souza D Viruses. 2023; 15(5).

PMID: 37243296 PMC: 10222392. DOI: 10.3390/v15051211.

Combination of the Focus-Forming Assay and Digital Automated Imaging Analysis for the Detection of Dengue and Zika Viral Loads in Cultures and Acute Disease.

Bolivar-Marin S, Bosch I, Narvaez C J Trop Med. 2022; 2022:2177183.

PMID: 35911823 PMC: 9325612. DOI: 10.1155/2022/2177183.

Natural products as Zika antivirals.

Fong Y, Chu J Med Res Rev. 2022; 42(5):1739-1780.

PMID: 35593443 PMC: 9540820. DOI: 10.1002/med.21891.

Brevinin-2GHk, a Peptide Derived from the Skin of , Inhibits Zika Virus Infection by Disrupting Viral Integrity.

Xiong W, Li J, Feng Y, Chai J, Wu J, Hu Y Viruses. 2021; 13(12).

PMID: 34960651 PMC: 8708736. DOI: 10.3390/v13122382.

References

DICK G, KITCHEN S, HADDOW A . Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg. 1952; 46(5):509-20. DOI: 10.1016/0035-9203(52)90042-4. View

. Zika virus infection: global update on epidemiology and potentially associated clinical manifestations. Wkly Epidemiol Rec. 2016; 91(7):73-81. View

Chibueze E, Tirado V, Lopes K, Balogun O, Takemoto Y, Swa T . Zika virus infection in pregnancy: a systematic review of disease course and complications. Reprod Health. 2017; 14(1):28. PMC: 5330035. DOI: 10.1186/s12978-017-0285-6. View

Faria N, da Silva Azevedo R, Kraemer M, Souza R, Cunha M, Hill S . Zika virus in the Americas: Early epidemiological and genetic findings. Science. 2016; 352(6283):345-349. PMC: 4918795. DOI: 10.1126/science.aaf5036. View

Petersen L, Jamieson D, Powers A, Honein M . Zika Virus. N Engl J Med. 2016; 374(16):1552-63. DOI: 10.1056/NEJMra1602113. View

Ventura C, Maia M, Bravo-Filho V, Gois A, Belfort Jr R . Zika virus in Brazil and macular atrophy in a child with microcephaly. Lancet. 2016; 387(10015):228. DOI: 10.1016/S0140-6736(16)00006-4. View

Jia K, Yuan Y, Liu W, Liu L, Qin Q, Yi M . Identification of Inhibitory Compounds Against Singapore Grouper Iridovirus Infection by Cell Viability-Based Screening Assay and Droplet Digital PCR. Mar Biotechnol (NY). 2017; 20(1):35-44. DOI: 10.1007/s10126-017-9785-1. View

Lu J, Hsieh P, Lin C, Hu M, Huang S, Wang Y . Synergistic effects of combination treatment using EGCG and suramin against the chikungunya virus. Biochem Biophys Res Commun. 2017; 491(3):595-602. DOI: 10.1016/j.bbrc.2017.07.157. View

Efferth T, Sauerbrey A, Halatsch M, Ross D, Gebhart E . Molecular modes of action of cephalotaxine and homoharringtonine from the coniferous tree Cephalotaxus hainanensis in human tumor cell lines. Naunyn Schmiedebergs Arch Pharmacol. 2003; 367(1):56-67. DOI: 10.1007/s00210-002-0632-0. View

10.

Espano E, Nam J, Song E, Song D, Lee C, Kim J . Lipophilic statins inhibit Zika virus production in Vero cells. Sci Rep. 2019; 9(1):11461. PMC: 6685969. DOI: 10.1038/s41598-019-47956-1. View

11.

Kuno G, Chang G . Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses. Arch Virol. 2007; 152(4):687-96. DOI: 10.1007/s00705-006-0903-z. View

12.

Adcock R, Chu Y, Golden J, Chung D . Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay. Antiviral Res. 2016; 138:47-56. DOI: 10.1016/j.antiviral.2016.11.018. View

13.

Romero M, Serrano M, Efferth T, Alvarez M, Marin J . Effect of cantharidin, cephalotaxine and homoharringtonine on "in vitro" models of hepatitis B virus (HBV) and bovine viral diarrhoea virus (BVDV) replication. Planta Med. 2007; 73(6):552-8. DOI: 10.1055/s-2007-967184. View

14.

Cao J, Forrest J, Zhang X . A screen of the NIH Clinical Collection small molecule library identifies potential anti-coronavirus drugs. Antiviral Res. 2014; 114:1-10. PMC: 7113785. DOI: 10.1016/j.antiviral.2014.11.010. View

15.

Teixeira M, Costa M, de Oliveira W, Nunes M, Rodrigues L . The Epidemic of Zika Virus-Related Microcephaly in Brazil: Detection, Control, Etiology, and Future Scenarios. Am J Public Health. 2016; 106(4):601-5. PMC: 4816003. DOI: 10.2105/AJPH.2016.303113. View

16.

Perard-Viret J, Quteishat L, Alsalim R, Royer J, Dumas F . Cephalotaxus Alkaloids. Alkaloids Chem Biol. 2017; 78:205-352. PMC: 7110560. DOI: 10.1016/bs.alkal.2017.07.001. View

17.

Chen J, Liang Y, Yi P, Xu L, Hawkins H, Rossi S . Outcomes of Congenital Zika Disease Depend on Timing of Infection and Maternal-Fetal Interferon Action. Cell Rep. 2017; 21(6):1588-1599. PMC: 5726784. DOI: 10.1016/j.celrep.2017.10.059. View

18.

Lee J, Loe M, Lee R, Chu J . Antiviral activity of pinocembrin against Zika virus replication. Antiviral Res. 2019; 167:13-24. DOI: 10.1016/j.antiviral.2019.04.003. View

19.

Zammarchi L, Stella G, Mantella A, Bartolozzi D, Tappe D, Gunther S . Zika virus infections imported to Italy: clinical, immunological and virological findings, and public health implications. J Clin Virol. 2015; 63:32-5. DOI: 10.1016/j.jcv.2014.12.005. View

20.

Agbulos D, Barelli L, Giordano B, Hunter F . Zika Virus: Quantification, Propagation, Detection, and Storage. Curr Protoc Microbiol. 2016; 43:15D.4.1-15D.4.16. DOI: 10.1002/cpmc.19. View